대웅제약

069620KOSPI

62.6 / 100

Reference Date: 2026-09-08

Financial Score32.5 / 40

News Sentiment18.1 / 25

Momentum5.0 / 20

Disclosure7.0 / 15

AI Analysis: PER is significantly undervalued vs. peers and ROE significantly exceeds the industry average is also solid. Declined 9.6% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Daewon Pharmaceutical, established in 2002, is a leading pharmaceutical company specializing in the production and sales of specialty drugs and high-purity botulinum toxin 'Nabohta'. In 2025, it achieved sales of 13.91 trillion KRW and operating profit of 2.04 trillion KRW, driven by global market expansion, AI-based digital healthcare solutions, and R&D investments in innovative drugs.

Number of Employees

1,794people

Average Salary

77.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

7.00Industry Average 15.008.0Point

Half of industry avg (excellent)

PBR

1.19Industry Average 1.204.0Point

In line with industry avg

ROE

18.71Industry Average 8.007.0Point

2.3x industry avg (excellent)

Debt Ratio

56.35Industry Average 100.005.0Point

Lower than industry avg (good)

Trend 2023~20258.5 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲6.9% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲26.8% (2-year basis)

ROE Trend

3.5 / 4

Avg ROE 11.9% (improving, 3yr)

Detailed News Sentiment

56 totalPositive 30Neutral 15Negative 11Average Sentiment Score 72.3

Negative
메디톡스, 대웅제약에 손배 청구 5000억으로 확대…'보톡스 전쟁' 격...
메디톡스와 대웅제약 간의 균주 출처 소송이 확대되면서 대웅제약의 손해배상 청구액이 증가하여 부정적 영향이 예상됨.
Neutral
독후감 쌓여 독창적 기술력으로…5평 사무실서 ‘K뷰티 산실’ 키워낸.....
The news focuses on the growth trajectory of a larger company, 한국콜마, rather than directly impacting 대웅제약's stock performance.
Negative
메디톡스 "대웅, 5001억 내놔"…판 커지는 보톡스 전쟁
대웅제약과 메디톡스 간의 보톡스 관련 소송이 확대되어 손해배상액이 증가함에 따라 대웅제약의 주가에 부정적 영향이 예상됩니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (10%, downtrend)

Current 116,600Won52-week high 194,00052-week low 107,300

1-month return1.0Point

1m -9.61% (falling)

Volume trend3.0Point

Volume flat

Detailed Disclosure

6 totalPositive 0Neutral 5Negative 1

Neutral타인에대한채무보증결정2026-09-04
Negative소송등의제기ㆍ신청(일정금액이상의청구)2026-09-02
Neutral의결권대리행사권유참고서류2026-08-25
Neutral주주총회소집공고2026-08-25
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-21